Word count: 1646 2 DISTAL MUSCLE INVOLVEMENT IN GM CAN MIMIC INCLUSION BODY MYOSITIS Abstract We report on four aged patients with chronic myopathy suggestive of sporadic inclusion body myositis. They presented progressive and selective weakness of the quadriceps femoris muscles. Asymmetric and selective atrophy of the forearm muscles was noted in all, with more severe involvement of the flexors than the extensors. Biopsy revealed granulomatous myositis. Histological features of s-IBM were lacking. Evidence for systemic sarcoidosis was found in one patient. Corticosteroid treatment was associated with partial but significant improvement in two patients. Granulomatous myositis may mimic inclusion body myositis and may be steroid-responsive.
Introduction
Sporadic IBM (s-IBM) is the most common acquired myopathy in patients over the age of 50, and involvement of the quadriceps and deep finger flexors are clues to its early diagnosis. [1] In contrast, granulomatous myositis (GM) is rare and found only in 0.4% of all muscle biopsy specimens. [2] We report on four aged patients with chronic myopathy suggestive of s-IBM, in whom muscle biopsy showed GM. Our four patients presented with progressive and relatively selective weakness of the quadriceps femoris muscles. Asymmetric and selective atrophy of the forearm muscles was also noted in all these patients, with more severe involvement of the flexors than the extensors. A diagnosis of s-IBM was made prior to muscle biopsy. Surprisingly, granulomas were found in muscle biopsy specimens obtained from these four patients, whereas no classical features of s-IBM could be identified.
Patients and Methods
Patients. The patients were three women and one man, aged between 76 and 84 at the time of muscle biopsy. None of them had a past history of sarcoidosis. Muscle biopsy was performed on extensor carpi radialis in all patients. This muscle is easily accessible and often informative, in our experience, for a diagnosis of s-IBM, which was first suspected.
Muscle Pathology. Muscle samples were conventionally processed for light microscopy using standard procedures. [3] Frozen sections were stained with hematoxylin-eosin (H&E), modified Gomori trichrome, Oil-red-O, periodic acid-Schiff (PAS), Congo Red and histoenzymatic reactions including NADH-tetrazolium reductase, succinate dehydrogenase, cytochrome C oxidase were performed. Several muscle fragments were paraffin-embedded and sections were stained with H&E.
Expression of major histocompatibility complex (MHC)-1 (Dakocytomation, Glostrup, Denmark), CD3, CD4, CD8, CD20, CD68 (Dakocytomation, Glostrup, Denmark), and SMI-31 (SMI-31R, Covance) were evaluated by immunoperoxidase assay performed on frozen sections, using an automated immunostainer (Ventana®, Tucson, Az). Sporadic IBM was excluded in all patients by the absence of rimmed vacuoles in muscle fibers, the absence of amyloid deposits on Congo Red staining viewed under a Rhodamine red filter, and the absence of tubulo-filamentous inclusions with SMI-31 immunohistochemistry. [4] Biopsy findings for all patients are described in the table and illustrated in the figure. However, review of the patient's medical records revealed that she presented bladder polyps eight years before, for which she had been treated with Bacillus Calmette Guérin (BCG) therapy for two years. While under treatment, bilateral uveitis developed, for which antituberculosis therapy was administered during one year, with no efficacy. A sarcoidosis workup was then carried out and uveitis remained isolated. Interferon alpha-2A treatment was then tried and effective against the uveitis. However, two months after the start of interferon therapy, the patient developed myalgia and muscular weakness, as mentioned above. Muscle biopsy was performed 12 months after interferon introduction, revealing muscle fiber necrosis, inflammation, and giganto-epithelioid granulomas. This led to the assumption that interferon treatment had caused the GM. [5] Indeed, shortly after interferon was withdrawn, the myalgia disappeared and muscular strength slowly improved. Corticosteroids were not applied.
Case Reports

Discussion
As opposed to other inflammatory myopathies in which weakness is mostly proximal, in s-IBM, distal muscles are involved. [6] Early in the course of the disease, weakness and atrophy is typically observed in the quadriceps femoris and forearm flexors, often asymmetric.
Sporadic IBM is not only the most frequent inflammatory myopathy encountered in patients aged 50 and over, but also the most likely diagnosis when a patient over 50 complains of falls and has atrophic thighs. [1] GM is clearly not as frequent and usually present with bilateral and symmetrical weakness of proximal lower limbs. [7] Distal involvement may be observed as the disease develops, but is rarely present at the outset. [7] It is therefore not surprising that our patients were first diagnosed with s-IBM.
Histological diagnosis of s-IBM is challenging, since the distribution of muscle abnormalities is patchy and the complete biopsy criteria may be missing even from clinically affected muscles. [8] Similarly, granuloma in muscle may be easily overlooked unless numerous paraffin sections are examined. Thorough histological investigation of frozen and paraffin sections of several muscle fragments are therefore essential for diagnosis in both situations.
Few cases of association between sarcoidosis or other autoimmune disorders and s-IBM have been described. [9] [10] [11] [12] In our muscle biopsy specimen, we did not detect amyloid or tubulofilamentous inclusions, which are markers of degenerative changes in s-IBM, [4] leading us to conclude that our patients just had GM.
The classically held view of s-IBM is that it clinically differs from other types of inflammatory myopathies by its male preponderance, muscle weakness, atrophy topography, and protracted course. Resistance to treatment with conventional forms of immunotherapy is 9 also a feature of s-IBM. [1] On the other hand, GM may be significantly improved by steroids, although such response is unpredictable. Discrepancies among various studies may be due to the different proportions of acute and chronic myositis cases included, since the former has a better response to steroids and a more benign course. [7] In our patients 1 and 3, who suffered from chronic myopathy, steroids were efficient.
The prevalence of granulomas in muscle biopsies is low, and sarcoidosis is known to be the single most commonly identifiable cause. [2] The prevalence of asymptomatic GM in sarcoidosis has been reported to be as high as 50-80%. [13] Symptomatic involvement is clearly less common, and includes various types: nodular, acute myositis, or the more common, chronic myopathy, as in patient 1, which is slower in onset and occurs later in life. [7] GM may also occur without systemic involvement. Although muscle pathology is similar to that seen in sarcoidosis, isolated GM is usually considered a separate clinicopathological entity. However, in most series and case reports, it remains unclear whether GM simply reflects an incomplete sarcoidosis work-up. [7] It is possible to speculate why some patients with GM present with a similar clinical pattern to s-IBM. It could be related to the level of expression of IL-1beta, which is high in sarcoid myopathy granuloma and s-IBM. [14, 15] In spite of the age of the patients with GM in this report, the mechanism of ageing could also contribute to the unique pattern of affected muscles in both diseases.
Regardless whether granulomatosis is systemic or limited to muscles, it can occur late in life and manifests as a chronic myopathy strongly suggestive of s-IBM. Corticosteroids should be 10 tried whenever GM is symptomatic. Although it is rare, recognizing GM remains important from both the prognostic and therapeutic points of view. 
